BeStock  
Stocks › Medical Devices › IRMD

IRadimed IRMD

US equityMarket cap rank #3182Medical Devices
$85.47 +$0.65 (+0.77%)
Pre-market · Oct 8, 8:20 am ET · After hours $85.47 0.00%
Open$84.55
Prev close$84.82
Day range$83.84 – $86.77
Volume197.9K
Market cap$1.09B
P/E (TTM)47.7
Dividend yield0.87%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$20.47M+0.3% YoY
Operating profit$6.39M-5.8% YoY
Net profit$5.22M-9.6% YoY
Diluted EPS$0.41-8.9% YoY
Free cash flow$5.50M+11.7% YoY
Operating cash flow$5.94M

Revenue, last 8 quarters

$18.3MSep '24$19.4MDec '24$19.5MMar '25$20.4MJun '25$21.2MSep '25$22.7MDec '25$22.0MMar '26$20.5MJun '26

Net profit, last 8 quarters

$5.0MSep '24$5.1MDec '24$4.7MMar '25$5.8MJun '25$5.6MSep '25$6.4MDec '25$5.8MMar '26$5.2MJun '26

Diluted EPS by quarter

0.40Sep '240.40Dec '240.37Mar '250.45Jun '250.43Sep '250.50Dec '250.45Mar '260.41Jun '26

Free cash flow by quarter

$5.1MSep '24$2.9MDec '24$375.0KMar '25$4.9MJun '25$5.7MSep '25$5.5MDec '25$7.8MMar '26$5.5MJun '26

Annual revenue

$31.7MFY20$41.8MFY21$53.3MFY22$65.6MFY23$73.2MFY24$83.8MFY25

Profitability & balance sheet

Gross margin75.9%
Operating margin31.9%
Net margin26.7%
Return on equity23.5%
Return on assets20.8%
Return on invested capital23.5%
Current ratio9.46
Liabilities / assets11.5%
Cash & investments$59.08M
Net cash (debt)$59.08M
Free cash flow / sales28.4%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $20.47M $21.98M $83.81M $22.69M $21.20M
Total Operating Revenue $20.47M $21.98M $83.81M $22.69M $21.20M
Cost of Revenue $5.31M $5.17M $19.49M $5.66M $4.71M
Gross Profit $15.16M $16.81M $64.32M $17.03M $16.49M
Operating Expense $8.77M $9.58M $38.18M $9.94M $9.66M
Selling and Admin Expenses $8.11M $8.62M $35.20M $9.14M $8.99M
-Selling & Marketing Expense $4.25M $4.05M $17.42M $4.60M $4.63M
-General & Admin Expense $3.87M $4.57M $17.78M $4.54M $4.36M
Research & Development $657,000.00 $956,000.00 $2.98M $799,031.00 $674,362.00
Operating Profit $6.39M $7.24M $26.15M $7.09M $6.83M
Other Income (Expense) $497,000.00 $532,000.00 $205,000.00 -$1.31M $463,976.00
Other Non-Operating Income (Expenses) $497,000.00 $532,000.00 – – $463,976.00
Pretax Profit $6.89M $7.77M $28.36M $7.79M $7.30M
Tax $1.67M $1.95M $5.88M $1.35M $1.72M
Net Profit $5.22M $5.82M $22.48M $6.44M $5.58M
Profit from Continuing Operations $5.22M $5.82M $22.48M $6.44M $5.58M
Net Income to Parent Company $5.22M $5.82M $22.48M $6.44M $5.58M
Net Income to Common Stockholders $5.22M $5.82M $22.48M $6.44M $5.58M
Basic EPS $0.41 $0.46 $1.77 $0.51 $0.44
Diluted EPS $0.41 $0.45 $1.75 $0.50 $0.43
Dividend Per Share $0.20 $0.20 $0.68 $0.17 $0.17
Net Non-Operating Interest Income (Expense) – – $2.01M – –
Non-Operating Interest Income – – $2.01M – –
Gain on Sale of Security – – $2,000.00 – –
Special Income (Charges) – – $203,000.00 – –
-Gain on Sale of Property/Plant/Equipment – – $203,000.00 – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $114.98M $114.39M $108.78M $108.78M $114.72M
Total Current Assets $86.72M $86.42M $81.20M $81.20M $84.92M
Cash and Cash Equivalents & Short-Term Investments $59.08M $56.37M $51.16M $51.16M $56.53M
-Cash and Cash Equivalents $59.08M $56.37M $51.16M $51.16M $56.53M
Receivables $13.19M $13.42M $13.67M $13.67M $13.86M
-Accounts Receivable $13.19M $13.42M $13.67M $13.67M $13.86M
Prepaid Assets $792,000.00 $3.13M – – $1.70M
Inventory $12.26M $11.88M $11.62M $11.62M $11.73M
Other Current Assets $1.40M $1.63M $4.76M $4.76M $1.10M
Total Non-Current Assets $28.25M $27.97M $27.57M $27.57M $29.80M
Net PPE $24.21M $24.23M $23.86M $23.86M $23.79M
-Gross PPE $29.88M $29.59M $28.93M $28.93M $28.66M
-Accumulated Depreciation -$5.67M -$5.36M -$5.07M -$5.07M -$4.87M
Goodwill and Other Intangible Assets $3.44M $3.29M $3.38M $3.38M $3.37M
-Other Intangible Assets $3.44M $3.29M $3.38M $3.38M $3.37M
Non-Current Deferred Assets $363,000.00 $231,000.00 $94,000.00 $94,000.00 $2.42M
Other Non-Current Assets $244,000.00 $225,000.00 $239,000.00 $239,000.00 $214,374.00
Total Liabilities $13.23M $15.88M $14.16M $14.16M $16.37M
Total Current Liabilities $9.16M $12.12M $10.18M $10.18M $12.80M
Payables $2.49M $6.51M $3.63M $3.63M $5.43M
-Accounts Payable $1.85M $2.18M $1.82M $1.82M $2.33M
-Total Tax Payable $641,000.00 $4.33M $1.81M $1.81M $3.10M
Current Accrued Expenses $3.06M $2.07M $3.22M $3.22M $4.07M
Current Provisions $146,000.00 $144,000.00 $144,000.00 $144,000.00 $137,025.00
Current Deferred Liabilities $3.47M $3.40M $2.87M $2.87M $3.16M
Total Non-Current Liabilities $4.06M $3.76M $3.98M $3.98M $3.57M
Non-Current Deferred Liabilities $4.06M $3.76M $3.98M $3.98M $3.57M
Total Equity $101.75M $98.51M $94.62M $94.62M $98.35M
Stockholders' Equity $101.75M $98.51M $94.62M $94.62M $98.35M
Capital Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,272.00
-Common Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,272.00
Additional Paid-In Capital $31.59M $31.02M $30.39M $30.39M $32.01M
Retained Earnings $70.15M $67.49M $64.23M $64.23M $66.34M
Other Current Liabilities – – $313,000.00 $313,000.00 –
Long Term Debt and Capital Lease Obligation – – $0.00 $0.00 $0.00
-Long Term Capital Lease Obligation – – $0.00 $0.00 $0.00
-Current Capital Lease Obligation – – – – $0.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $5.94M $8.29M $24.95M $5.92M $6.99M
Net cash flow from continuing operations $5.94M $8.29M $24.95M $5.92M $6.99M
Net Income from Continuing Operations $5.22M $5.82M $22.48M $6.44M $5.58M
Depreciation & Depletion & Amortization $410,000.00 $455,000.00 $1.17M $380,680.00 $383,320.00
Deferred Tax -$132,000.00 -$137,000.00 $2.73M $2.33M $134,987.00
Change in Working Capital -$344,000.00 $1.42M -$4.35M -$3.95M $222,620.00
-Change in Receivables $280,000.00 $212,000.00 -$3.03M $191,434.00 -$2.89M
-Change in Inventory -$515,000.00 -$534,000.00 -$1.38M $53,911.00 -$559,911.00
-Change in Prepaid Assets $2.56M $7,000.00 -$2.71M -$1.96M -$546,050.00
-Change in Payables and Accrued Expense -$3.03M $1.41M $1.33M -$2.34M $4.07M
-Change in Other Current Assets -$18,000.00 $13,000.00 -$40,000.00 -$24,538.00 -$9,462.00
-Change in Other Current Liabilities $0.00 $0.00 -$150,000.00 $0.00 $0.00
-Change In Other Working Capital $380,000.00 $305,000.00 $1.62M $125,191.00 $157,809.00
Net cash flow from investing -$443,000.00 -$469,000.00 -$8.42M -$416,407.00 -$1.26M
Net Cash Flow from Continuing Investing Activities -$443,000.00 -$469,000.00 -$8.42M -$416,407.00 -$1.26M
Capital Expenditure -$258,000.00 -$66,000.00 -$656,000.00 -$122,233.00 -$125,767.00
Net PPE Purchase and Sale -$185,000.00 -$403,000.00 -$7.77M -$294,174.00 -$1.14M
Financing Cash Flow -$2.79M -$2.61M -$17.60M -$10.87M -$2.19M
Net Cash Flow from Continuing Financing Activities -$2.79M -$2.61M -$17.60M -$10.87M -$2.19M
Cash Dividends Paid -$2.56M -$2.56M -$15.04M -$8.55M -$2.16M
Net Other Financing Charges -$234,000.00 -$50,000.00 -$2.56M -$2.32M -$29,850.00
Ending Cash Balance $59.08M $56.37M $51.16M $51.16M $56.53M
Net Change in Cash $2.71M $5.22M -$1.08M -$5.37M $3.53M
Beginning Cash Balance $56.37M $51.16M $52.23M $56.53M $53.00M
Free Cash Flow $5.50M $7.82M $16.53M $5.51M $5.72M
Gain/Loss from Continuing Operations – – $37,000.00 $2,848.00 $33,152.00
Proceeds from Stock Option Exercised – – $0.00 $0.00 –

Discussion

No comments yet — be the first to weigh in on IRMD.

Leave a comment

Scroll to Top